The suit alleges that the commission must complete a supply-and-demand analysis before soliciting new license applications, and the company insists the current supply is sufficient to meet demand.
A spokesman for Curio told the Baltimore Sun the company was “compelled to file this action to protect their businesses investments.”
To read more about the lawsuit, click here.
What's next for infused products? Manufacturers must cater to demand for CBD, rapid onset and microdosing to stay ahead.
And so the deck is stacked once again in the hands of big cannabis. What are you really afraid of here Curio? That minority owned businesses might actually succeed and take some of your profits away? This sends a mixed message, one that teeters on racism.